Insmed | GJELD



Debt Endring Dato
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
DBV Technologies USD 0 0 2024-09
Dynavax Technologies USD 223.85M 293K 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
Insmed USD 1.13B 147.86M 2024-12
Novartis USD 31.26B 828M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Insmed GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.